SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-19-014735
Filing Date
2019-03-19
Accepted
2019-03-19 06:06:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM S-1 tv515716-s1a.htm S-1/A 564423
2 EXHIBIT 23.1 tv515716_ex23-1.htm EX-23.1 2894
3 GRAPHIC lg_outlook-therapeutics.jpg GRAPHIC 47309
  Complete submission text file 0001144204-19-014735.txt   633669
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-1/A | Act: 33 | File No.: 333-229761 | Film No.: 19690116
SIC: 2836 Biological Products, (No Diagnostic Substances)